CMS Mulls About-Face in Coverage of GLP-1 Treatments for Obesity: Report

Earlier this year, the Centers for Medicare and Medicaid Services scrapped a previous proposal, from the Biden administration, to include anti-obesity medications in Medicare Part D coverage.

Scroll to Top